Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PDSA Asks Stakeholders To Join DSCSA Track-And-Trace Governing Body By September

Executive Summary

But there’s a wrinkle: Many prospective participants cannot budget for the tiered fees until 2020.

You may also be interested in...



New DSCSA Track And Trace Governing Body Up And Running

Despite some previous uncertainty about sufficient funding commitments from members, the coalition of manufacturers, wholesalers and distributors is operational, with a meeting planned for early next year. It will oversee data governance systems for implementing the US supply chain safety law, a key element of the law's third phase set to go into effect November 2023.

DSCSA Pilot Explores Feasibility Of Food Blockchain Program For Pharmaceutical Track-And-Trace Compliance

Safe lettuce to safe pills? Participants in a US FDA pilot program are seeing if a food tracking blockchain program can also be used to track pharmaceuticals under a DSCSA pilot program now underway; KPMG officials touts data security as one of the main advantages of blockchain.

Potential Governing Body Emerges For DSCSA Tracing Of US-Marketed Drug Packages

The idea of establishing a non-profit governance group to coordinate the package-level tracing of pharmaceuticals through the US distribution chain that DSCSA requires drew widespread support at a May 1 PDSA meeting in Washington, DC. PDSA wants to get the group up and running by October.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS140667

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel